Laboratory of Addiction Genetics Makes Important Discovery in Methamphetamine Addiction
EurekAlert.org reported that researchers in the Laboratory of Addiction Genetics in the Department of Pharmacology & Experimental Therapeutics and Psychiatry at Boston University School of Medicine have identified a gene that may be linked to methamphetamine addiction. The article, “Hnrnph1 is a Quantative Trait Gene for Methamphetamine Sensitivity”Hnrnph1 is a Quantative Trait Gene for Methamphetamine […]
Dr. David Farb’s research is highlighted in “Neurophysiology Charges Ahead,” Science 2015
In his recent article, “Neurophysiology Charges Ahead,” Alan Dove reviews recent advances in electrophysiology and genetic approaches to neuroscience. The research of Dr. David Farb, Director and Principal Investigator of the Laboratory of Molecular Neurobiology in the Department of Pharmacology & Experimental Therapeutics at Boston University, among others, is highlighted. Noting the evolution of electrophysiology […]
The Pharmacologist September 2015 Issue is Now Available
September 2015 – Volume 57, Issue 3 In This Issue: Message from the President: Dr Kenneth E. Thummel EB2016 Meeting Highlights Feature Article: Sleepy Sickness, Oliver Sacks, and the Early Days of L-Dopa Science Policy News Education News Journal News Membership News Members in the News Division News Chapter News Meetings and Congresses
Joon Ying Boon and Megan Varnum Participate in the 25th Annual BUMC Art Days and GMS Student Art Exhibit
Joon Ying Boon and Megan Varnum, Program in Biomolecular Pharmacology Ph.D. graduate students, contributed to the success of 25th Annual BUMC Art Days, March 30-31, 2015. BUMC students, faculty and staff were invited to contribute paintings, photos, poetry, sculpture, needlework, etc. for the event. This year’s keyword was INTERSECT and a special display section was […]
Dr. Carol Walsh Presents BUSDM Dental Pharmacology Integrated Problem Session to ADEA Annual Meeting
Carol Walsh, Ph.D., Pharmacology Vice Chair for Education, presented a description of the innovative Integrated Problem Sessions of the BUSDM Dental Pharmacology course at a symposium held March 9 at the American Dental Education Association (ADEA) annual meeting in Boston. The symposium, organized by Aldo Leone, D.M.D.,Associate Dean for Academic Affairs at BUSDM, was entitled […]
University-wide Graduate Program for Neuroscience Receives BU Provost’s CEIT Interdisciplinary Course Development Grant
Congratulations go to Shelley J. Russek, Ph.D., Professor Pharmacology & Experimental Therapeutics and Biology, and the University-wide Graduate Program for Neuroscience (GPN) on being awarded the Boston University Provost’s Center for Excellence and Innovation in Teaching (CEIT) Interdisciplinary Course Development Grant. As GPN Director, Shelley spearheads a university-wide team of outstanding faculty who do an […]
Dr. Neil Ganem Receives Smith Family Foundation Award
Neil J. Ganem, Ph.D., Assistant Professor of Pharmacology & Experimental Therapeutics and Medicine at the Boston University School of Medicine, has received a 2014 Smith Family Foundation Award for Excellence in Biomedical Research. This prestigious, highly competitive three-year award of $300,000 is intended to help launch the careers of newly independent biomedical researchers. Since 1992, the program […]
BUSM Named Second Most Beautiful Medical School in the U.S.
Boston University Medical Campus is located in the historic South End of the capital city of Massachusetts. Well-known for the high quality of teaching, research, and community service, the school provides an exceptional learning environment for its students in the heart of the city. Article originally posted on BestMedicalDegrees.com.
Researchers Identify Tumor Suppressor Pathway that Monitors Chromosome Number
The Laboratory of Cancer Cell Biology has identified the tumor suppressor mechanism that prevents the oncogenic growth of cells harboring an abnormal number of chromosomes. The study, published in the journal Cell, was led by Neil J. Ganem, PhD. Tetraploid cells, which are a common byproduct of cell division failure, are genomically unstable and have the capacity to […]
BUSM Researchers Uncover New Possible Approach for Treating Schizophrenia
Researchers at Boston University School of Medicine (BUSM) have uncovered important clues about a biochemical pathway in the brain that may one day expand treatment options for cognitive deficits seen in schizophrenia. The study, published online in the journal Molecular Pharmacology, was led by faculty members David H. Farb, PhD, Terrell T. Gibbs, PhD, and Shelley […]